This topic contains a solution. Click here to go to the answer

Author Question: A drug company seeking to develop a new antischizophrenic drug would want to develop a drug that ... (Read 68 times)

piesebel

  • Hero Member
  • *****
  • Posts: 565
A drug company seeking to develop a new antischizophrenic drug would want to develop a drug that reverses both positive and negative symptoms but that avoids the blockage of ________ receptors within the ________ of the schizophrenic brain.
 
  a. D1; nucleus accumbens
  b. D2; medial prefrontal cortex
  c. D3; hippocampus
  d. D2; striatum
  e. D4; amygdala

Question 2

Patients with _____________ are unable to stop moving. This condition is common among individuals who take antipsychotic medications.
 
  a. Parkinson's disease
  b. Huntington's disease
  c. tardive dyskinesia
  d. paroxysmal dyskinesia
  e. athetosis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yasmin

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

Answer: d. D2; striatum

Answer to Question 2

Answer: c. tardive dyskinesia




piesebel

  • Member
  • Posts: 565
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


cici

  • Member
  • Posts: 325
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library